Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.6400
+0.0400
+(2.50%)
At close: April 4 at 4:00:01 PM EDT
1.6430
+0.00
+(0.18%)
After hours: April 4 at 7:41:28 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.41 | -1.04 | -1.46 | -1.53 |
| EPS Actual | 1.03 | -1.42 | -1.46 | -1.16 |
| Difference | 2.45 | -0.38 | -0 | 0.37 |
| Surprise % | 172.79% | -36.21% | -0.34% | 24.18% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| QTTB | -- | -- | -- | -- |
| S&P 500 | 6.59% | 6.64% | 9.81% | 16.08% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/12/2025 |
| Downgrade | BMO Capital: Outperform to Market Perform | 2/11/2025 |
| Downgrade | Piper Sandler: Overweight to Neutral | 2/11/2025 |
| Maintains | BMO Capital: Outperform to Outperform | 12/12/2024 |
| Downgrade | Guggenheim: Buy to Neutral | 12/12/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 12/11/2024 |
Related Tickers
DSGN Design Therapeutics, Inc.
3.4000
-3.41%
FHTX Foghorn Therapeutics Inc.
3.4400
+9.21%
PLRX Pliant Therapeutics, Inc.
1.3400
+2.29%
NGNE Neurogene Inc.
8.79
-9.10%
ATXS Astria Therapeutics, Inc.
4.6550
-9.61%
MOLN Molecular Partners AG
3.5694
-4.05%
TRML Tourmaline Bio, Inc.
12.83
-2.21%
PMVP PMV Pharmaceuticals, Inc.
1.0000
+0.50%
ALXO ALX Oncology Holdings Inc.
0.5159
-3.23%
PHVS Pharvaris N.V.
14.28
-2.33%